|
|
| Zeile 5: |
Zeile 5: |
| | | | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32354181|t=2020. Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis |pdf=|usr=}}
| |
| − | {{tp|p=32340107|t=2020. The Use of Digital Health in the Detection and Management of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32295188|t=2020. Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review |pdf=|usr=}}
| |
| − | {{tp|p=32171952|t=2020. The SARS-CoV-2 outbreak: What we know |pdf=|usr=}}
| |
| − | {{tp|p=32247050|t=ä. Insight into 2019 novel coronavirus ? an updated intrim review and lessons from SARS-CoV and MERS-CoV |pdf=|usr=}}
| |
| − | {{tp|p=32236624|t=2020. A new threat from an old enemy: Re-emergence of coronavirus (Review) |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 83: |
Zeile 77: |
| | | | |
| | *'''[[Diagnosis (Laboratory)]]''' | | *'''[[Diagnosis (Laboratory)]]''' |
| − | {{tp|p=32371192|t=ä. Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus |pdf=|usr=}}
| |
| − | {{tp|p=32251798|t=2020. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32344011|t=2020. Mild versus severe COVID-19: Laboratory markers |pdf=|usr=}}
| |
| − | {{tp|p=32315809|t=ä. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously |pdf=|usr=}}
| |
| − | {{tp|p=32114193|t=2020. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests |pdf=|usr=}}
| |
| − | {{tp|p=32370065|t=2020. Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
| |
| − | {{tp|p=32344568|t=2020. RT-qPCR Testing of SARS-CoV-2: A Primer |pdf=|usr=}}
| |
| − | {{tp|p=32276333|t=2020. Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens |pdf=|usr=}}
| |
| − | {{tp|p=32325642|t=2020. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| Zeile 115: |
Zeile 99: |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32173574|t=2020. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis |pdf=|usr=}}
| |
| − | {{tp|p=32353549|t=ä. Coronavirus disease 2019 in pregnancy |pdf=|usr=}}
| |
| − | {{tp|p=32335339|t=ä. Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count |pdf=|usr=}}
| |
| − | {{tp|p=32335338|t=ä. Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: A retrospective study |pdf=|usr=}}
| |
| − | {{tp|p=32331343|t=2020. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 143: |
Zeile 122: |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | *[https://www.infowars.com/experts-suggest-90-million-oxford-university-coronavirus-vaccine-doesnt-work/ Oxford vaccine failed in monkeys]
| |
| − | {{tp|p=32305009|t=ä. Investigating hypothiocyanite against SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32173576|t=2020. Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression |pdf=|usr=}}
| |
| − | {{tp|p=32218340|t=2020. Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?|pdf=|usr=}}
| |
| − | {{tp|p=32354030|t=2020. Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work |pdf=|usr=}}
| |
| − | {{tp|p=32325767|t=2020. COVID-19 Drug Discovery Using Intensive Approaches |pdf=|usr=}}
| |
| − | {{tp|p=32353978|t=2020. Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 177: |
Zeile 149: |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32354081|t=2020. The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) in Dentistry Management of Biological Risk in Dental Practice |pdf=|usr=}}
| |
| − | {{tp|p=32316337|t=2020. COVID-19 Pandemic and the Crisis of Health Systems: The Experience of the Apulia Cancer Network and of the Comprehensive Cancer Center Istituto Tumori "Giovanni Paolo II" of Bari |pdf=|usr=}}
| |
| − | {{tp|p=32346207|t=ä. Hitting the reset button for hospitality research in times of crisis: Covid19 and beyond |pdf=|usr=}}
| |
| − | {{tp|p=32327741|t=ä. How the andrological sector suffered from the dramatic Covid 19 outbreak in Italy: supportive initiatives of the Italian Association of Andrology (SIA) |pdf=|usr=}}
| |
| − | {{tp|p=32286520|t=ä. How sexual medicine is facing the outbreak of COVID-19: experience of Italian urological community and future perspectives |pdf=|usr=}}
| |
| − | {{tp|p=32292637|t=2020. Application of refined management in prevention and control of the coronavirus disease 2019 epidemic in non-isolated areas of a general hospital? |pdf=|usr=}}
| |
| − | {{tp|p=32292636|t=2020. Contingency management strategies of the Nursing Department in centralized rescue of patients with coronavirus disease 2019? |pdf=|usr=}}
| |
| − | {{tp|p=C7129371|t=ä. Safety management of nasopharyngeal specimen collection from suspected cases of coronavirus disease 2019? |pdf=|usr=}}
| |
| − | {{tp|p=C7128134|t=ä. Emergency management of nursing human resources and supplies to respond to coronavirus disease 2019 epidemic? |pdf=|usr=}}
| |
| − |
| |
| | ---- | | ---- |
| | | | |
| Zeile 200: |
Zeile 162: |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| − | https://www.unzensuriert.at/content/102399-krankenhaus-in-kalifornien-meldet-mehr-selbstmorde-als-corona-tote/ inc. suicide rates in california
| |
| − | {{tp|p=32344809|t=2020. Psychological and Behavioral Responses in South Korea During the Early Stages of Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32340349|t=2020. Discrimination and Social Exclusion in the Outbreak of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32331344|t=2020. Hand Hygiene, Mask-Wearing Behaviors and Its Associated Factors during the COVID-19 Epidemic: A Cross-Sectional Study among Primary School Students in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32326274|t=2020. Visiting Policies of Hospice Wards during the COVID-19 Pandemic: An Environmental Scan in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32283285|t=2020. Adoption of personal protective measures by ordinary citizens during the COVID-19 outbreak in Japan |pdf=|usr=}}
| |
| − | {{tp|p=32372892|t=ä. Validation and Psychometric Evaluation of the Italian Version of the Fear of COVID-19 Scale |pdf=|usr=}}
| |
| − | {{tp|p=32226353|t=ä. The Fear of COVID-19 Scale: Development and Initial Validation |pdf=|usr=}}
| |
| − | {{tp|p=32346359|t=ä. Functional Fear Predicts Public Health Compliance in the COVID-19 Pandemic |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| Zeile 233: |
Zeile 185: |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32353991|t=2020. Early Transmission Dynamics of Novel Coronavirus (COVID-19) in Nigeria |pdf=|usr=}}
| |
| − | {{tp|p=32290445|t=2020. The Relationship between the Migrant Population s Migration Network and the Risk of COVID-19 Transmission in China-Empirical Analysis and Prediction in Prefecture-Level Cities |pdf=|usr=}}
| |
| − | {{tp|p=32316165|t=2020. Naive Forecast for COVID-19 in Utah Based on the South Korea and Italy Models-the Fluctuation between Two Extremes |pdf=|usr=}}
| |
| − | {{tp|p=32232402|t=ä. COVID-19 epidemic: disentangling the re-emerging controversy about medical facemasks from an epidemiological perspective |pdf=|usr=}}
| |
| − | {{tp|p=32160889|t=2020. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics |pdf=|usr=}}
| |
| − | {{tp|p=32234343|t=ä. Monitoring Transmissibility and Mortality of COVID-19 in Europe |pdf=|usr=}}
| |
| − | {{tp|p=32194239|t=2020. Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster |pdf=|usr=}}
| |
| − | {{tp|p=32179137|t=2020. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32007643|t=2020. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32088339|t=ä. The basic reproduction number of novel coronavirus (2019-nCoV) estimation based on exponential growth in the early outbreak in China from 2019 to 2020: A reply to Dhungana |pdf=|usr=}}
| |
| − | {{tp|p=32088335|t=ä. Comments on "Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven Analysis in the early phase of the outbreak" |pdf=|usr=}}
| |
| − | {{tp|p=31953166|t=2020. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health ? The latest 2019 novel coronavirus outbreak in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32276044|t=2020. The serostatus approach to fighting COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32360943|t=ä. Pilgrimage and COVID-19: the risk among returnees from Muslim countries |pdf=|usr=}}
| |
| − | {{tp|p=32360941|t=ä. Effective Reproductive Number estimation for initial stage of COVID-19 pandemic in Latin American Countries |pdf=|usr=}}
| |
| − | {{tp|p=32360938|t=2020. Mubarak(AU) Corona and clergy - The missing link for effective social distancing in Pakistan: Time for some unpopular decisions |pdf=|usr=}}
| |
| − | {{tp|p=32251790|t=2020. Severe acute respiratory syndrome (SARS) and coronavirus disease-2019 (COVID-19): From causes to preventions in Hong Kong |pdf=|usr=}}
| |
| − | {{tp|p=32251789|t=2020. Spatial epidemic dynamics of the COVID-19 outbreak in China |pdf=|usr=}}
| |
| − | {{tp|p=32360552|t=ä. COVID-19?We urgently need to start developing an exit strategy |pdf=|usr=}}
| |
| − | {{tp|p=32353547|t=ä. COVID-19 and Nigeria: Putting the realities in context |pdf=|usr=}}
| |
| − | {{tp|p=32339723|t=ä. Estimating instant case fatality rate of COVID-19 in China |pdf=|usr=}}
| |
| − | {{tp|p=32339715|t=ä. Statistical and network analysis of 1212 COVID-19 patients in Henan, China |pdf=|usr=}}
| |
| − | {{tp|p=32334116|t=ä. A self-assessment of the Thai Department of Disease Control s communication for international response at early phase to the COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32334117|t=2020. Evaluation and prediction of the COVID-19 variations at different input population and quarantine strategies, a case study in Guangdong province, China |pdf=|usr=}}
| |
| − | {{tp|p=32334115|t=ä. Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32325276|t=ä. Epidemic update of COVID-19 in Hubei Province compared with other regions in China |pdf=|usr=}}
| |
| − | {{tp|p=32247826|t=ä. Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster |pdf=|usr=}}
| |
| − | {{tp|p=32320809|t=ä. Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate |pdf=|usr=}}
| |
| − | {{tp|p=32315808|t=ä. The relative transmissibility of asymptomatic cases among close contacts |pdf=|usr=}}
| |
| − | {{tp|p=32171948|t=ä. The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China |pdf=|usr=}}
| |
| − | {{tp|p=32198088|t=ä. Transmission potential and severity of COVID-19 in South Korea |pdf=|usr=}}
| |
| − | {{tp|p=32145466|t=ä. Serial interval of novel coronavirus (COVID-19) infections |pdf=|usr=}}
| |
| − | {{tp|p=32145465|t=ä. A conceptual model for the outbreak of Coronavirus disease 2019 (COVID-19) in Wuhan, China with individual reaction and governmental action |pdf=|usr=}}
| |
| − | {{tp|p=32119980|t=2020. Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future |pdf=|usr=}}
| |
| − | {{tp|p=32097725|t=2020. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 298: |
Zeile 215: |
| | | | |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32361759|t=ä. SARS, MERS and COVID-19?new threats; old lessons |pdf=|usr=}}
| |
| − | {{tp|p=32199457|t=2020. Responding to the COVID-19 pandemic in complex humanitarian crises |pdf=|usr=}}
| |
| − | {{tp|p=32194236|t=2020. Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS-CoV-2 to fragile health systems of southern hemisphere countries this winter?|pdf=|usr=}}
| |
| − | {{tp|p=32088598|t=2020. First respiratory transmitted food borne outbreak?|pdf=|usr=}}
| |
| − | {{tp|p=32311449|t=2020. SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital |pdf=|usr=}}
| |
| − | {{tp|p=32283283|t=2020. Positive effects of COVID-19 control measures on influenza prevention |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
